Patent · US Expired

Low fluorescence assay platforms and related methods for drug discovery

US6517781B1 · kind B1 · utility

7Cited by
4References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 3, 2000
Grant dateFeb 11, 2003
Priority date
Expiry dateJan 3, 2020

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2021/0346
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

One aspect of the present invention is a multi-well platform for fluorescence measurements, comprising a plurality of wells within a frame, wherein the multi-well platform has low fluorescence background. Another aspect of the present invention is a system for spectroscopic measurements, comprising reagents for an assay and a multi-well platform for fluorescence measurements. A further aspect of the present invention is a method for detecting the presence of an analyte in a sample contained in a multi-well platform by detecting light emitted from the sample. Another aspect of the present invention is a method from identifying a modulator of a biological process or target in a sample contained in a multi-well platform by detecting light emitted from the sample. Another aspect of the present invention is a composition identified by this method. A further aspect of the present invention is a method to identify a therapeutic. A further aspect of the present invention is a method of testing a therapeutic for therapeutic activity and toxicology by identifying a therapeutic using a method of the present invention and monitoring the toxicology and efficacy of the therapeutic in an in vivo …

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.